Key statistics
As of last trade Bruker Corp (BKD:STU) traded at 50.24, 8.46% above its 52-week low of 46.32, set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 50.24 |
---|---|
High | 50.24 |
Low | 50.24 |
Bid | 53.50 |
Offer | 53.84 |
Previous close | 50.30 |
Average volume | 50.00 |
---|---|
Shares outstanding | 151.60m |
Free float | 103.23m |
P/E (TTM) | 27.11 |
Market cap | 8.52bn USD |
EPS (TTM) | 2.07 USD |
Annual div (ADY) | 0.1909 EUR |
---|---|
Annual div yield (ADY) | 0.38% |
Div ex-date | Aug 30 2024 |
Div pay-date | Sep 16 2024 |
Next div ex-date | Dec 02 2024 |
Next div pay-date | Dec 16 2024 |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Bruker Announces Quarterly Dividend
- Bruker Corporation to Present at Upcoming Investor Conferences
- Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
- Bruker Reports Third Quarter 2024 Financial Results
- Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
- Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
- European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
- Bruker Announces Formation of New Bruker Spatial Biology Division
- Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
- Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
More ▼